Development and application of a polymicrobial, in vitro, wound biofilm model

Journal of Applied Microbiology

Volumn 112, Issue 5, 2012, Pages 998-1006

  Woods, J ^a   Boegli, L ^a   Kirker, K R ^a   Agostinho, A M ^a   Durch, A M ^a   deLancey Pulcini, E ^a   Stewart, P S ^a   James, G A ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

Biofilm; Chronic wounds; Clostridium perfringens; Model; Polymicrobial; Pseudomonas aeruginosa; Staphylococcus aureus

Indexed keywords

CLOSTRIDIUM;

BIOFILM MODELS; CHRONIC WOUNDS; CLOSTRIDIUM PERFRINGENS; DEVELOPMENT AND APPLICATIONS; FLOW REACTORS; IN-VITRO; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; POLYMICROBIAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

BIOFILMS;

ANOXIC CONDITIONS; ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOFILM; GROWTH; HABITAT TYPE; HOMOGENEITY; MICROBIAL ACTIVITY; NUMERICAL MODEL; OXYGEN;

ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATION; BIOFILM; CLOSTRIDIUM PERFRINGENS; COLONY FORMING UNIT; CONTINUOUS FLOW REACTOR; CONTROLLED STUDY; DRIP FLOW REACTOR; GAUZE DRESSING; HOMOGENATE; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL GROWTH; NONHUMAN; OXYGEN CONSUMPTION; PLATE COUNT; PSEUDOMONAS AERUGINOSA; WOUND; WOUND DRESSING;

CLOSTRIDIUM PERFRINGENS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84859615314     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2012.05264.x     Document Type: Article

References (39)

1. Agostinho, A., Hartman, A., Lipp, C., Parker, A., Stewart, P. and James, G. (2011) An in vitro model for the growth and analysis of chronic wound MRSA biofilm. J Appl Microbiol 111, 1275-1282.
2. Allen, M.J., White, G.F. and Morby, A.P. (2006) The response of Escherichia coli to exposure to the biocide polyhexamethylene biguanide. Microbiology 152, 989-1000.
3. Ammons, M.C., Ward, L.S., Fisher, S.T., Wolcott, R.D. and James, G.A. (2009) In vitro susceptibility of established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa treated with lactoferrin and xylitol. Int J Antimicrob Agents 33, 230-236.
4. Ammons, M.C., Ward, L.S., Dowd, S. and James, G.A. (2011a) Combined treatment of Pseudomonas aeruginosa biofilm with lactoferrin and xylitol inhibits the ability of bacteria to respond to damage resulting from lactoferrin iron chelation. Int J Antimicrob Agents 37, 316-323.
5. Ammons, M.C., Ward, L.S. and James, G.A. (2011b) Anti-biofilm efficacy of a lactoferrin/xylitol wound hydrogel used in combination with silver wound dressings. Int Wound J 8, 268-273.
6. Bowler, P.G. (1998) The anaerobic and aerobic microbiology of wounds: a review. WOUNDS 10, 170-178.
7. Bowler, P.G., Duerden, B.I. and Armstrong, D.G. (2001) Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 14, 244-269.
8. Buckingham-Meyer, K., Goeres, D.M. and Hamilton, M.A. (2007) Comparative evaluation of biofilm disinfectant efficacy tests. J Microbiol Methods 70, 236-244.
9. Cazzaniga, A.L., Serralta, V., Davis, S., Orr, R., Eaglstein, W.H. and Mertz, P.M. (2002) The effect of an antimicrobial gauze dressing impregnated with 0.2-percent polyhexamethylene biquanide as a barrier to prevent Pseudomonas aeruginosa wound invasion. WOUNDS 14, 169-176.
10. Dalton, T., Dowd, S.E., Wolcott, R.D., Sun, Y., Watters, C., Griswold, J.A. and Rumbaugh, K.P. (2011) An in vivo polymicrobial biofilm wound infection model to study interspecies interactions. PLoS ONE 6, e27317.
11. Desrosiers, M., Myntti, M. and James, G. (2007) Methods for removing bacterial biofilms: in vitro study using clinical chronic rhinosinusitis specimens. Am J Rhinol 21, 527-532.
12. Dowd, S.E., Sun, Y., Secor, P.R., Rhoads, D.D., Wolcott, B.M., James, G.A. and Wolcott, R.D. (2008a) Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 8, 43.
13. Dowd, S.E., Wolcott, R.D., Sun, Y., McKeehan, T., Smith, E. and Rhoads, D. (2008b) Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS ONE 3, e3326.
14. Falanga, V. (2004) The chronic wound: impaired healing and solutions in the context of wound bed preparation. Blood Cells Mol Dis 32, 88-94.
15. Gallant-Behm, C.L., Yin, H.Q., Liu, S., Heggers, J.P., Langford, R.E., Olson, M.E., Hart, D.A. and Burrell, R.E. (2005) Comparison of in vitro disc diffusion and time kill-kinetic assays for the evaluation of antimicrobial wound dressing efficacy. Wound Repair Regen 13, 412-421.
16. Guggenbichler, J.P., Boswald, M., Lugauer, S. and Krall, T. (1999) A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters. Infection 27(Suppl 1), S16-S23.
17. Hammond, A.A., Miller, K.G., Kruczek, C.J., Dertien, J., Colmer-Hamood, J.A., Griswold, J.A., Horswill, A.R. and Hamood, A.N. (2011) An in vitro biofilm model to examine the effect of antibiotic ointments on biofilms produced by burn wound bacterial isolates. Burns 37, 312-321.
18. Herigstad, B., Hamilton, M. and Heersink, J. (2001) How to optimize the drop plate method for enumerating bacteria. J Microbiol Methods 44, 121-129.
19. James, G.A., Swogger, E., Wolcott, R., Pulcini, E., Secor, P., Sestrich, J., Costerton, J.W. and Stewart, P.S. (2008) Biofilms in chronic wounds. Wound Repair Regen 16, 37-44.
20. Kirker, K.R., Fisher, S.T., James, G.A., McGhee, D. and Shah, C.B. (2009a) Efficacy of polyhexamethylene biguanide-containing antimicrobial foam dressing against MRSA relative to standard foam dressing. WOUNDS 21, 229-233.
21. Kirker, K.R., Secor, P.R., James, G.A., Fleckman, P., Olerud, J.E. and Stewart, P.S. (2009b) Loss of viability and induction of apoptosis in human keratinocytes exposed to Staphylococcus aureus biofilms in vitro. Wound Repair Regen 17, 690-699.
22. Kostenko, V., Lyczak, J., Turner, K. and Martinuzzi, R.J. (2010) Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment. Antimicrob Agents Chemother 54, 5120-5131.
23. Leaper, D.J. (2006) Silver dressings: their role in wound management. Int Wound J 3, 282-294.
24. Lee, W.R., Tobias, K.M., Bemis, D.A. and Rohrbach, B.W. (2004) In vitro efficacy of a polyhexamethylene biguanide-impregnated gauze dressing against bacteria found in veterinary patients. Vet Surg 33, 404-411.
25. Lipp, C., Kirker, K., Agostinho, A., James, G. and Stewart, P. (2010) Testing wound dressings using an in vitro wound model. J Wound Care 19, 220-226.
26. Lo, S.F., Chang, C.J., Hu, W.Y., Hayter, M. and Chang, Y.T. (2009) The effectiveness of silver-releasing dressings in the management of non-healing chronic wounds: a meta-analysis. J Clin Nurs 18, 716-728.
27. Motta, G.J., Milne, C.T. and Corbett, L.Q. (2004) Impact of antimicrobial gauze on bacterial colonies in wounds that require packing. Ostomy Wound Manage 50, 48-62.
28. Rasmussen, K. and Lewandowski, Z. (1998) Microelectrode measurements of local mass transport rates in heterogeneous biofilms. Biotechnol Bioeng 59, 302-309.
29. Rezaei, E., Safari, H., Naderinasab, M. and Aliakbarian, H. (2011) Common pathogens in burn wound and changes in their drug sensitivity. Burns 37, 805-807.
30. Schierholz, J.M., Lucas, L.J., Rump, A. and Pulverer, G. (1998) Efficacy of silver-coated medical devices. J Hosp Infect 40, 257-262.
31. Secor, P.R., James, G.A., Fleckman, P., Olerud, J.E., McInnerney, K. and Stewart, P.S. (2011) Staphylococcus aureus Biofilm and Planktonic cultures differentially impact gene expression, mapk phosphorylation, and cytokine production in human keratinocytes. BMC Microbiol 11, 143.
32. Sen, C.K., Gordillo, G.M., Roy, S., Kirsner, R., Lambert, L., Hunt, T.K., Gottrup, F., Gurtner, G.C. et al. (2009) Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 17, 763-771.
33. Shimizu, T., Ohtani, K., Hirakawa, H., Ohshima, K., Yamashita, A., Shiba, T., Ogasawara, N., Hattori, M. et al. (2002) Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater. Proc Natl Acad Sci U S A 99, 996-1001.
34. Thomsen, T.R., Aasholm, M.S., Rudkjobing, V.B., Saunders, A.M., Bjarnsholt, T., Givskov, M., Kirketerp-Moller, K. and Nielsen, P.H. (2010) The bacteriology of chronic venous leg ulcer examined by culture-independent molecular methods. Wound Repair Regen 18, 38-49.
35. Thorn, R.M. and Greenman, J. (2009) A novel in vitro flat-bed perfusion biofilm model for determining the potential antimicrobial efficacy of topical wound treatments. J Appl Microbiol 107, 2070-2079.
36. Vermeulen, H., van Hattem, J.M., Storm-Versloot, M.N. and Ubbink, D.T. (2007) Topical silver for treating infected wounds. Cochrane Database Syst Rev, CD005486.
37. Wolcott, R.D. and Rhoads, D.D. (2008) A study of biofilm-based wound management in subjects with critical limb ischaemia. J Wound Care 17, 145-148, 150-142, 154-145.
38. Wolcott, R.D., Rumbaugh, K.P., James, G., Schultz, G., Phillips, P., Yang, Q., Watters, C., Stewart, P.S. et al. (2010) Biofilm maturity studies indicate sharp debridement opens a time- dependent therapeutic window. J Wound Care 19, 320-328.
39. Xu, K.D., Stewart, P.S., Xia, F., Huang, C.T. and McFeters, G.A. (1998) Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability. Appl Environ Microbiol 64, 4035-4039.